Unauthorized Use of Content on this Site: The responses, guidance, and advisories provided by the Pharmaceutical Advertising Advisory Board (PAAB)—including, but not limited to, those available through the PAAB Forum, the PAAB website, and any PAAB correspondence—are specifically intended to assist individuals navigating the PAAB preclearance system. Repurposing or reproducing this content, or using it for model training or any related purposes, is strictly prohibited without the express prior written consent of PAAB. This includes, but is not limited to, the use of such materials in automated systems, machine learning models, or artificial intelligence applications.
FYI for a price update?
-
We have a recently approved APS that includes the price of the product. If the price changes, and we make just that one change to the piece, can this be handled with an FYI email?
-
Hey @charlton
Please send the requested revision in as an FYI and we will assess if it meets the spirit of an FYI request.
